Avalo Therapeutics Inc.

4.78
-0.10 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
4.67
-2.30%
After-hours: Apr 25, 2025, 04:21 PM EDT

Avalo Therapeutics Revenue

Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending December 31, 2024, Avalo Therapeutics generated $192K in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
51.01M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 441K -77.08%
Dec 31, 2023 1.92M -89.34%
Dec 31, 2022 18.05M +234.40%
Dec 31, 2021 5.4M -19.42%
Dec 31, 2020 6.7M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.